Potential for Bruton's tyrosine kinase inhibitors as additional antiplatelet agents in acute coronary syndromes

Bhatti, M., Michail, O., Ayton, S., Gollop, N. D., Ryding, A., Rushworth, S., Bowles, K. ORCID: https://orcid.org/0000-0003-1334-4526 and Flather, M. (2018) Potential for Bruton's tyrosine kinase inhibitors as additional antiplatelet agents in acute coronary syndromes. European Heart Journal, 39 (Supplement 1). p. 747. ISSN 0195-668X

Full text not available from this repository. (Request a copy)

Item Type:	Article
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Cancer Studies Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023) Faculty of Medicine and Health Sciences > Research Groups > Norwich Clinical Trials Unit Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health
Depositing User:	LivePure Connector
Date Deposited:	06 May 2020 00:07
Last Modified:	25 Sep 2024 14:39
URI:	https://ueaeprints.uea.ac.uk/id/eprint/75039
DOI:	10.1093/eurheartj/ehy563.P3612

Actions (login required)

View Item